Hasil Pencarian - Paul Emery

Perbaiki Hasil
  1. 1
    The Role of the Microbiome in Driving RA-Related Autoimmunity

    The Role of the Microbiome in Driving RA-Related Autoimmunity oleh Cristopher M. Rooney, Kulveer Mankia, Kulveer Mankia, Paul Emery, Paul Emery

    Diterbitkan 2020-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on “At-Risk” Individuals

    The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on “At-Risk” Individuals oleh Laurence Duquenne, Laurence Duquenne, Rahaymin Chowdhury, Kulveer Mankia, Kulveer Mankia, Paul Emery, Paul Emery

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Efficacy, tolerability and safety of biologic therapy in rheumatoid disease: patient considerations

    Efficacy, tolerability and safety of biologic therapy in rheumatoid disease: patient considerations oleh Sarah Horton, Maya H Buch, Paul Emery

    Diterbitkan 2010-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Recent advances in ankylosing spondylitis: understanding the disease and management [version 1; referees: 2 approved]

    Recent advances in ankylosing spondylitis: understanding the disease and management [version 1; referees: 2 approved] oleh Leticia Garcia-Montoya, Hanna Gul, Paul Emery

    Diterbitkan 2018-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    DNA Hypomethylation in the TNF-Alpha Gene Predicts Rheumatoid Arthritis Classification in Patients with Early Inflammatory Symptoms

    DNA Hypomethylation in the TNF-Alpha Gene Predicts Rheumatoid Arthritis Classification in Patients with Early Inflammatory Symptoms oleh Rujiraporn Pitaksalee, Rekha Parmar, Richard Hodgett, Paul Emery, Frederique Ponchel

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective study.

    LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective study. oleh Yune-Jung Park, Chul-Soo Cho, Paul Emery, Wan-Uk Kim

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Experimental infection of Asian house geckos with Enterococcus lacertideformus demonstrates multiple disease transmission routes and the in-vivo efficacy of antibiotics

    Experimental infection of Asian house geckos with Enterococcus lacertideformus demonstrates multiple disease transmission routes and the in-vivo efficacy of antibiotics oleh Jessica E. Agius, Karrie Rose, Jon-Paul Emery, David N. Phalen

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis

    The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis oleh Yoshiya Tanaka, Josef S. Smolen, Heather Jones, Annette Szumski, Lisa Marshall, Paul Emery

    Diterbitkan 2019-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    The role of ultrasonography in rheumatology

    The role of ultrasonography in rheumatology oleh Kok Ooi Kong, Damien Loeuille, Yohei Seto, Richard J. Wakefield, Paul Emery

    Diterbitkan 2003-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab

    Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab oleh Sabih Ul Hassan, Sabih Ul Hassan, Md Yuzaiful Md Yusof, Md Yuzaiful Md Yusof, Paul Emery, Paul Emery, Shouvik Dass, Shouvik Dass, Edward M. Vital, Edward M. Vital

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Subcutaneous Sarilumab in Patients With Rheumatoid Arthritis who Previously Received Subcutaneous Sarilumab or Intravenous Tocilizumab: An Open‐Label Extension of a Randomized Clinical Trial

    Subcutaneous Sarilumab in Patients With Rheumatoid Arthritis who Previously Received Subcutaneous Sarilumab or Intravenous Tocilizumab: An Open‐Label Extension of a Randomized Clin... oleh Paul Emery, Hubert vanHoogstraten, Karthinathan Thangavelu, Erin Mangan, Gregory St John, Patrick Verschueren

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data

    Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data oleh Paul Emery, Daniel E. Furst, Petra Kirchner, Simone Melega, Stuart Lacey, Patricia B. Lehane

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy

    Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy oleh Hanna Gul, Andrea Di Matteo, Innocent Anioke, Farag Shuweidhi, Kulveer Mankia, Frederique Ponchel, Paul Emery

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis

    A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis oleh Jack Arnold, Edward M. Vital, Edward M. Vital, Shouvik Dass, Shouvik Dass, Aamir Aslam, Aamir Aslam, Andy C. Rawstron, Sinisa Savic, Sinisa Savic, Paul Emery, Paul Emery, Md Yuzaiful Md Yusof, Md Yuzaiful Md Yusof

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis

    Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis oleh Paul Emery, Yoshiya Tanaka, Tracy Cardillo, Douglas Schlichting, Terence Rooney, Scott Beattie, Cameron Helt, Josef S. Smolen

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis

    Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis oleh Paul Emery, Yoshiya Tanaka, Tracy Cardillo, Douglas Schlichting, Terence Rooney, Scott Beattie, Cameron Helt, Josef S. Smolen

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals

    Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals oleh Paul Emery, K Mankia, Laurence Duquenne, Farag Shuweihdi, L A Trouw, Frederique Ponchel, Diane Corscadden, Xuanxiao Xie

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis—a comprehensive review

    Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis—a comprehensive review oleh Paul Emery, Patrick Durez, Axel J. Hueber, Inmaculada de la Torre, Esbjörn Larsson, Thorsten Holzkämper, Yoshiya Tanaka

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function

    IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function oleh Laura A. Ridgley, Amy E. Anderson, Nicola J. Maney, Najib Naamane, Andrew J. Skelton, Catherine A. Lawson, Catherine A. Lawson, Paul Emery, Paul Emery, John D. Isaacs, John D. Isaacs, Ruaidhrí J. Carmody, Arthur G. Pratt, Arthur G. Pratt

    Diterbitkan 2019-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program.

    Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program. oleh Paul Emery, William Rigby, Paul P Tak, Thomas Dörner, Ewa Olech, Carmen Martin, Laurie Millar, Helen Travers, Elena Fisheleva

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: